ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Finds Three Chemicals Pose Risk Of Cncer to Humans; 38 More Will Go On Test

August 5, 1977

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002

Clearinghouse Opens With Predictable Controversy; Brown Urges ‘Open Minds’

November 12, 1976

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982